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for endometrial lesions. Eligible literature was identified 
from systematic PubMed searches, and the relevant data 
were extracted. Comments, letters, unpublished data, con-
ference proceedings, and case reports were excluded from 
our search. Seventy-four articles on endometrial sampling 
devices were obtained for this review.
Results The main screening devices for endometrial car-
cinoma are aspiration devices (such as the Vabra aspira-
tor), Pipelle, Tao Brush, and SAP-1 device. Among these 
devices, the Tao Brush is the most promising endometrial 
sampler for screening for endometrial lesions. However, 
its sampling insufficiency, cost, and unsuccessful insertion 
rate (20 % in nulliparous and 8 % in parous women) are 
problematic.
Conclusions A more accurate and low-cost endometrial 
sampler, with improved specimen sufficiency and higher 
sensitivity for endometrial lesions, needs tobe developed 
and clinically verified.
Keywords Endometrial lesions · Aspiration · Biopsy · 
Brush · Screening
Abbreviation
D&C  Dilatation and curettage
Introduction
Endometrial carcinoma is the most common gynecologic 
malignancy in western countries (Bray et al. 2005; Siegel 
et al. 2013), as well as in developed cities in China such as 
Beijing, Shanghai, and Zhongshan. It has supplanted cervical 
cancer as the leading gynecological malignancy (Siegel et al. 
2013, 2014; Gao et al. 2015). With the increasing morbidity 
and mortality of endometrial carcinoma around the world, 
Abstract 
Purpose Endometrial carcinoma is the most common 
gynecologic malignancy in both developed and some devel-
oping countries. Unlike cervical cancer, for which there is 
routine screening, only patients symptomatic for endome-
trial carcinoma typically seek medical help for its diagno-
sis and treatment. Dilatation and curettage (D&C) has been 
the standard procedure for evaluating suspicious endome-
trial lesions. The discomfort and injury caused by the D&C 
procedure, however, restrict its use as a screening method 
for early diagnosis of endometrial lesions. High-risk endo-
metrial cancer patients would benefit from an effective and 
low-cost screening test. In recent years, several endometrial 
devices have been developed and proposed as screening 
tools.
Methods We have reviewed and evaluated the literature 
relating to the endometrial sampling devices in clinical 
use or clinical trials, with the goal of comparing devices 
and identifying the most appropriate ones for screening 
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there would be social and economic benefit from a screening 
tool that could be used for early detection, leading to earlier 
treatment of endometrial carcinoma. Unfortunately, unlike 
cervical cancer, no effective and low-cost screening program 
for early detection of endometrial carcinoma has been estab-
lished at this time (Broso 1995). Curetting is still the standard 
procedure for evaluating endometrial lesions such as carci-
noma and hyperplasia, but this procedure has several deficien-
cies. Besides of its tendency to cause pain and injury, as well 
as its cost (Tabata et al. 2001), curetting can only evaluate less 
than half of the uterine cavity in approximately 60 % of dila-
tation and curettage (D&C) procedures, which can result in 
false-negative diagnoses (Kipp et al. 2008). Therefore, there 
is an urgent need for alternative devices which can be used for 
early detection of endometrial lesions, especially carcinoma 
and its precursors. Since the 1970s, several uterine sampling 
devices which show relatively high sensitivity and specificity 
for early diagnosis of endometrial lesions have been devel-
oped for screening for endometrial lesions (Longacre et al. 
1995; Bistoletti and Hjerpe 1993; Vuopala et al. 1989; Tajima 
et al. 1998; vanHoeven et al. 1996). This review provides an 
overview of available endometrial devices for sampling and 
early diagnosis of endometrial lesions, critically evaluates the 
advantages and deficits of these samplers, and suggests con-
siderations for future development of such devices.
Methods
A literature search from January 1, 1990 to July 10, 2015 
was performed using PubMed for articles about endome-
trial devices. The keywords used included “aspiration tech-
nology for endometrium,” “endometrial aspiration device,” 
“Pipelle biopsy,” “brush for endometrium,” “brush for 
endometrial carcinoma,” “Tao Brush”, and “SAP-1 device.” 
Searches were restricted to human studies and English lan-
guage publications, and other articles concerning endome-
trial pathology were excluded. Seventy-four relevant arti-
cles on endometrial sampling devices were obtained for our 
review. Citation lists of retrieved articles were checked to 
ensure sensitivity of the search methods.
Results
The main screening devices for endometrial carcinoma are 
aspiration devices, Pipelle, Tao Brush, and SAP-1 brush 
sampler, as outlined in Fig. 1.
Aspiration devices
Aspiration technology was described by Bela Lorincz, in 
1934, as a method with few complications that could be used 
in an outpatient setting. More recently, aspiration technology 
has been shown to be a safe, simple, and reliable technique 
for screening for endometrial lesions (Hemalatha et al. 2006; 
Kaur et al. 2014; Kawana et al. 2005; Roberts et al. 1994; Ros-
ler et al. 1991; Morse et al. 1982; Niklasson et al. 1981; Pop-
pendiek and Bayer 1981; Masukawa 1981; Smith et al. 1980). 
Among all of the aspiration devices, the Vabra aspirator is 
most commonly used for clinical trials to evaluate endometrial 
lesions. The Vabra aspirator is a metal cannula with a length 
of 24 cm and an external diameter of 3 mm. At the inner side 
of the curved ending, it has an aperture of 1.5 × 16 mm. The 
cannula is connected to a plastic receptacle, which contains a 
sieve, also of plastic material, to retain the fragments of tis-
sue. After insertion of the cannula into the uterine cavity, the 
pump is switched on. The two proximal openings in the can-
nula are covered by an index finger to create negative pressure, 
while holding the plastic receptacle of the Vabra aspirator. As 
a result, the uterus is emptied by suction, and then the cannula 
is withdrawn from the uterus briefly. The procedure is then 
repeated several times to make sure that the whole interior sur-
face of the uterus is sampled (Lubbers 1977).
In one study, the specimens obtained by aspiration 
were adequate for cytology in 93 % of cases, among 150 
patients (Tripathy and Mahanty 1990). In a symptomatic 
group of 100 women, a specificity of 88.7 % and a sensi-
tivity of 88.2 % were found, in comparison to histological 
diagnosis, with only 2 % of the results being false nega-
tive. The use of aspiration in endometrial cell sampling also 
seems to be promising as a screening tool in asymptomatic 
women (Rosler et al. 1991). In an article by Rodriguez 
et al., twenty-five patients who were scheduled for hyster-
ectomy were randomly assigned to undergo preoperative 
endometrial biopsy by Pipelle device (discussed below) 
(12 patients) or Vabra aspiration (13 patients). The Vabra 
aspirator was shown to be statistically superior in sampling 
Fig. 1  Ways to collect endometrium
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the percentage of endometrial surface, the mean number of 
endometrial surfaces, and the mean number of endometrial 
quadrants (Rodriguez et al. 1993).
Though aspiration sampling could reduce costs com-
pared with curettage, one limitation is that it may be per-
ceived as a procedure for abortion-related treatment in 
some countries where abortion is illegal (Foster-Rosales 
et al. 2003). The procedure success rate to collect endome-
trium in the Vabra was shown to be less than the Pipelle 
(88.7 % vs. 98.7, P = 0.02). Cost-benefit analysis by Naim 
et al. revealed a higher average cost per patient in the Vabra 
group compared to the Pipelle group (Naim et al. 2007). 
Additional limitations of the Vabra aspirator were that 
in some cases it did not result in adequate endometrium 
being obtained and did not allow diagnosis of other uter-
ine pathologies, such as endometrial polyps and uterine 
myoma (Leonardi et al. 1993). As Goldberg et al. reported, 
the Vabra aspirator could not be inserted in five out of 40 
patients because of cervical stenosis (Goldberg et al. 1982). 
Kaunitz et al. compared the performance of the Pipelle 
to the Vabra aspirator in 50 patients, and found that the 
Pipelle obtained more tissue than the Vabra in 28 patients 
(50 %), and was noted by the clinician to cause less pain in 
50 patients (89 %). Forty-seven patients (84 %) stated that 
biopsy with Pipelle was less painful than with Vabra aspira-
tor (Kaunitz et al. 1988; Wu et al. 2000).
Other aspirators such as Accurette (Kriseman 1982), 
Isaacs cell sampler (Polson et al. 1984), manual vacuum 
aspiration (Foster-Rosales et al. 2003; Kitiyodom 2015), and 
corkscrew (Sierecki et al. 2008) have also been used for eval-
uating endometrial lesions, but they have not been extensively 
applied in the clinic because of a lack of supporting data.
Pipelle
Introduced by Cornier in 1984 (Eddowes et al. 1990), 
the Pipelle is the most studied biopsy device in the 
literature (Eddowes et al. 1990; Youssif and Mcmillan 
1995; Eddowes et al. 1990; Leng et al. 2013; Fakhar et al. 
2008; Elsandabesee and Greenwood 2005; Machado et al. 
2003; Dijkhuizen et al. 2000; Sundsbak and Jebsen 1994; 
Zorlu et al. 1994; Sanam and Majid 2015; Ben-baruch et al. 
1994; Leclair et al. 2011). The Pipelle device is 23.5 mm 
in length, with a polypropylene sheath with an outer diam-
eter of 3.1 mm. Suction is created along a negative pres-
sure gradient when the inner plunger is withdrawn (Leclair 
et al. 2011). The Pipelle endometrial sampler can be used 
without cervical dilatation in the outpatient department and 
causes minimum discomfort.
As compared to traditional D&C, Pipelle sampling is a 
less time-consuming procedure (Sanam and Majid 2015; 
Rauf et al. 2014). The specimen satisfaction rate of Pipelle, 
according to articles from 1994 to 2015, ranged from 73.9 
to 100 %. Meanwhile, pathological accuracy was 62.0 to 
96.9 % for endometrial lesions (Leng et al. 2013; Fakhar 
et al. 2008; Machado et al. 2003; Zorlu et al. 1994; Sanam 
and Majid 2015; Rauf et al. 2014; Gungorduk et al. 2014; 
Kazandi et al. 2012; Guido et al. 1995; Ben-Baruch et al. 
1994), with greater acceptability for patients than D&C 
(Table 1).
Although adequate tissue for histopathologic examination 
was obtained in slightly fewer cases than for D&C (98 vs. 
100 %), the acceptability of the Pipelle was 98 % and of the 
D&C was 34 % in a study by Raufet al. (Rauf et al. 2014). In 
a meta-analysis by Dijkhuizen et al. the results of Pipelle sam-
pling were compared with other surgeries such as D&C, hys-
teroscopy, or hysterectomy between 1996 and 1999, and the 
conclusion was that the Pipelle was the best device for detect-
ing endometrial lesions in both postmenopausal and pre-
menopausal women, with detection rates of 99. 6 and 91 %, 
respectively (Fakhar et al. 2008). In the study of Demirkiran 
et al., 673 patients were evaluated by Pipelle biopsy from 
October 2007 to November 2009. Compared with patho-
logical examination after hysterectomy, the histological 
Table 1  Review of the literature on Pipelle biopsy for diagnosis of endometrial lesions
Year References Cases Curettage or  
hysterectomy




2015 Sanam and Majid (2015) 130 130 130 88.0 94.0
2014 Rauf et al. (2014) 203 101 102 98 –
2014 Gungorduk et al. (2014) 267 189 78 – 62.0
2013 Leng et al. (2013) 200 200 200 93.0 85.0
2012 Kazandi et al. (2012) 82 82 82 93.0 66.0
2008 Fakhar et al. (2008) 100 100 100 98.0 94.0
2003 Machado et al. (2003) 1535 168 1535 73.9 96.9
1995 Guido et al. (1995) 65 65 65 97.0 83.0
1994 Zorlu et al. (1994) 26 26 26 100 95.0
1994 Ben-baruch et al. (1994) 269 97 172 90.6 95.5
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concordance rate was only 67 % for Pipelle biopsy and 70 % 
for D&C. The sensitivity of Pipelle biopsy and D&C was 
both 99 %, but Pipelle was easier to perform than D&C for 
surgeons (Demirkiran et al. 2012). Gungorduk et al. evalu-
ated patients undergoing hysterectomy for various indications 
via Pipelle endometrial biopsy or D&C from 2009 to 2011. A 
total of 267 women were included, with 78 women enrolled 
in the Pipelle group and 189 in the D&C group. The concord-
ance rate with histological diagnosis between Pipelle biopsy 
and hysterectomy was 62 %, and between D&C and hyster-
ectomy was 67 %. Pipelle biopsy and D&C were equally suc-
cessful for diagnosing endometrial lesions (Gungorduk et al. 
2014). Abdelazim et al. compared the diagnostic sensitivity 
of Pipelle with D&C in patients undergoing abnormal uterine 
bleeding; the rate of obtaining adequate endometrium for his-
tological diagnosis was 100 % for D&C and 97.9 % for the 
Pipelle group. The sensitivity of Pipelle biopsy was 100 % for 
endometrial hyperplasia, endometrial carcinoma, prolifera-
tive, and secretory endometrium, whereas the sensitivity for 
diagnosing endometritis was 88.9 % (Abdelazim et al. 2013). 
Pipelle was also shown to be useful in obtaining endometrial 
tissue for hormonal evaluation (Check et al. 1989), as well as 
in patients treated with progestin for endometrial hyperplasia 
(Kim et al. 2015).
However, other reports describe the limitations of the 
Pipelle biopsy. It may be less efficient than other methods 
as a screening tool, because only a small proportion of the 
endometrial surface can be sampled (Batool et al. 1994), 
and furthermore, the Pipelle biopsy has limited ability 
to identify focal lesions (Kazandi et al. 2012). In Tanri-
verdi et al.’s report, 13 patients in the D&C group and 29 
patients in the Pipelle group had insufficient tissue, among 
127 patients. The authors concluded that Pipelle sampling 
should be reserved for those patients with only a minimal 
risk for endometrial carcinoma, hyperplasia, and polyps 
(Tanriverdi et al. 2004). The sensitivity and specificity of 
Pipelle in endometrial samplings were compared to frac-
tional curettage in postmenopausal patients and found to 
be 87.5 and 100 %, respectively. One out of three cases of 
endometrial adenocarcinoma could not be diagnosed by 
Pipelle (Bunyavejchevin et al. 2001). Tumors localized to 
a polyp or a small area of endometrium may go undetected 
with Pipelle (Guido et al. 1995), and the Pipelle procedure 
is almost eight times as costly as D&C (Rauf et al. 2014). 
The Pipelle also showed its limitations for diagnosing 
endometrial polyps, with a sensitivity of only 60 % in the 
report by Abdelazim et al. (2013).
Tao Brush
The Tao Brush was introduced in 1993 and approved by the 
Food and Drug Administration for general medical use (Tao 
1997) (Fig. 2a). To begin collection of endometrial cells, the 
sheath is pulled back, and then the brush is inserted at the 
level of the fundus through the cervical canal. The 3.5-cm 
brush is then rotated 360° 3–5 times to collect endometrial 
cells. The outer sheath is then pushed back to the tip, and 
the device is removed from the uterine cavity. The brush is 
cut off and immersed into cell preservation liquids and sent 
for cytological assessment and diagnosis (Kipp et al. 2008).
The Tao Brush can be used in an outpatient setting, 
without the need for anesthetic, as it is simple to use and 
appears to be well tolerated by women. Specimen satisfac-
tion with the Tao Brush, according to articles from 1997 to 
2003, was 89.9 to 100 %, while the pathological accuracy 
was 91.0 to 96.0 % (Wu et al. 2000, 2003 Maksem et al. 
1997; Del Priore et al. 2001) (Table 2).
There was less specimen insufficiency for diagnosis 
with the Tao Brush (2 %) than with the Pipelle (12 %). 
Additionally, the Tao Brush was significantly less painful 
than Pipelle (P < 0.01) (Yang and Wan 2000). In Del Pri-
ore et al.’s study, the Tao Brush had 95.5 % sensitivity and 
the Pipelle had 86 % sensitivity, when correlated with the 
final diagnosis (Del Priore et al. 2001). The sensitivity and 
specificity were 100 % for detecting atypical hyperplasia 
and carcinoma with Tao Brush in 200 cases in the report of 
Wu et al. (2000). Williams et al. found that adequate sam-
ples were significantly more likely to be obtained using the 
Tao Brush than the Pipelle among 200 high-risk women. A 
significantly greater proportion of women preferred the Tao 
Brush to the Pipelle endometrial sampler (Williams et al. 
2008).
However, it was difficult using the Tao Brush to distin-
guish simple hyperplasia without atypia from disordered 
proliferative endometrium or to diagnose endometrial pol-
yps, according to Wu et al. (2000). Insertion of the Tao 
Brush was unsuccessful in 20 % of nulliparous women and 
8 % of parous women, whereas Pipelle was unsuccessful 
in 22 % of attempts among nulliparous women compared 
with 8 % of parous women in Williams’ research. The 
Fig. 2  Three types of brushes for endometrial cytology. a Tao Brush; 
b Li Brush; c SAP-1 endometrial sampler
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additional cost of the Tao Brush biopsy compared to the 
Pipelle biopsy was approximately £100 (Williams et al. 
2008). Also, in theory, the Tao Brush has the disadvan-
tage of not collecting enough endometrial cells of the uter-
ine horns because of its round configuration.
SAP‑1 device
The SAP-1 device (Fig. 2b) was patented and received per-
mission to be used in China in 2001. The sheath of this sam-
pler is approximately 3 mm in diameter and 25 cm in length. 
This protective sheath outside the loop can prevent contami-
nation with cervical and vaginal cells (Wen et al. 2015). To 
collect endometrial cells, the device is first inserted to the 
level of the fundus and then the outer sheath pulled back, 
and then the loop is rotated in a clockwise direction for 15 
circles. After collecting enough endometrial cells, the outer 
sheath is pushed to the tip and the device removed.
The SAP-1 sampler may become a reliable method for 
screening endometrial carcinoma and its precursors, espe-
cially in postmenopausal and asymptomatic women. In 
the study by Wen et al., adequate specimens for cytology 
were obtained from 1458/1541 patients (96.3 %) using the 
SAP-1 sampler. The accuracy of endometrial cytology for 
diagnosing endometrial carcinoma and its precursors was 
92.4 % (sensitivity, 73 %; specificity, 95.8 %; positive pre-
dictive value, 75 %; and negative predictive value, 95.3 %) 
(Wen et al. 2015). However, there have not been enough 
clinical trials to date supporting the feasibility of the SAP-1 
device. Like the Tao Brush, in theory, the SAP-1 device 
also will not adequately collect cells in the uterine horn.
Other samplers such as the Uterobrush (Fujihara et al. 
2006; Iavazzo et al. 2011), Medscand Endorette (Moberger 
et al. 1998), Cytospat (Antoni et al. 1997), Endopap (Van 
den Bosch et al. 1996), Tis-U-Trap (Koonings et al. 1990a, 
b; Frishman and Jacobs 1990), Honest Uterine Brush 
(Yanoh et al. 2014) have also been used in the clinic, but 
reports detailing their use appear less often in the literature.
Li brush
Due to the limitations of the samplers described above, 
our team invented a new endometrial sampler, named 
the Li Brush (Fig. 2c), which received a patent in 2014 
(ZL.201420720356.8). Compared with other samplers, the 
Li Brush was designed as an inverted cone, similar in shape 
to the uterine cavity. In theory, this Brush can collect more 
endometrial cells than possible with other samplers, espe-
cially cells in the uterine horns (Fig. 2), allowing a more 
accurate diagnosis of endometrial lesions. Clinical trials of 
the Li Brush have been launched in outpatient and inpatient 
clinics in the Department of Gynecology of the First Affili-
ated Hospital, Xi’an Jiaotong University (XJTU1AHCR 
2014-007).
Conclusions and future challenges
All of the devices described herein for evaluating endome-
trial changes have some disadvantages or limitations for 
clinical use. It appears that in clinical trials the Tao Brush 
provides more accurate diagnoses, specimen satisfac-
tion, and pathological accuracy for detecting endometrial 
lesions. However, sampling insufficiency and costs remain 
problems that need to be solved for effective screening 
of endometrial lesions. The devices being developed for 
endometrial screening should possess the following char-
acteristics. First of all, the screening tool should collect as 
much endometrial specimen as possible for evaluation and 
diagnosis, especially cells in the uterine horns. Second, the 
endometrial specimen should accurately reflect the condi-
tion of the uterine cavity to more accurately guide clinical 
intervention and treatment. Furthermore, the screening tool 
should be cost-effective in order to be used in a wide range 
of women for early detection of endometrial lesions, with 
the goal of improving the prognosis of endometrial car-
cinoma. Thus, additional efforts should be undertaken to 
develop an endometrial screening device that could provide 
more complete histological and cytological information 
about the uterine cavity, which could be widely used by the 
female population.
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